Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study

[1] Czerwinski E(2007)Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation Ortop Traumatol Rehabil 9 337-356

[2] Badurski JE(2012)Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) Curr Med Res Opin 28 475-491

[3] Marcinowska-Suchowierska E(2011)Epidemiology of hip fracture: worldwide geographic variation Indian J Orthop 45 15-22

[4] Osieleniec J(2007)Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025 J Bone Miner Res 22 465-475

[5] Cooper C(2006)An estimate of the worldwide prevalence and disability associated with osteoporotic fractures Osteoporos Int 17 1726-1733

[6] Reginster JY(2001)Consensus development panel on osteoporosis prevention, diagnosis, and therapy, March 7–29, 2000: highlights of the conference South Med J 94 569-573

[7] Cortet B(2001)Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update Arthritis Rheum 44 1496-1503

[8] Diaz-Curiel M(2006)Importance of early diagnosis and treatment of osteoporosis to prevent fractures Am J Manag Care 12 S181-S190

[9] Lorenc RS(1994)Assessment of fracture risk and its application to screening for postmenopausal osteoporosis World Health Organ Tech Rep Ser 843 1-129

[10] Kanis JA(2005)Predictive value of BMD for hip and other fractures J Bone Miner Res 20 1185-1194

[1] Czerwinski E(2007)Current understanding of osteoporosis according to the position of the World Health Organization (WHO) and International Osteoporosis Foundation Ortop Traumatol Rehabil 9 337-356

[2] Badurski JE(2012)Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF) Curr Med Res Opin 28 475-491

[3] Marcinowska-Suchowierska E(2011)Epidemiology of hip fracture: worldwide geographic variation Indian J Orthop 45 15-22

[4] Osieleniec J(2007)Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025 J Bone Miner Res 22 465-475

[5] Cooper C(2006)An estimate of the worldwide prevalence and disability associated with osteoporotic fractures Osteoporos Int 17 1726-1733

[6] Reginster JY(2001)Consensus development panel on osteoporosis prevention, diagnosis, and therapy, March 7–29, 2000: highlights of the conference South Med J 94 569-573

[7] Cortet B(2001)Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update Arthritis Rheum 44 1496-1503

[8] Diaz-Curiel M(2006)Importance of early diagnosis and treatment of osteoporosis to prevent fractures Am J Manag Care 12 S181-S190

[9] Lorenc RS(1994)Assessment of fracture risk and its application to screening for postmenopausal osteoporosis World Health Organ Tech Rep Ser 843 1-129

[10] Kanis JA(2005)Predictive value of BMD for hip and other fractures J Bone Miner Res 20 1185-1194